Abnormal gene is a triple threat in driving pediatric brain tumors

An abnormal fused gene that drives pediatric brain tumors poses a triple threat, operating simultaneously through three distinct biological mechanisms -- the first such example in cancer biology. This finding potentially offers triple benefits as well -- more accurate diagnoses, clues for more effective treatments and new insights into molecular processes underlying other types of cancer.